Financial statements Ozawo
Balance sheet data of OZAWO
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
|---|---|---|---|---|---|---|---|
| Total assets | 386 480,59 | 1 220 265,45 | 1 645 407,88 | 1 883 233,99 | 2 843 115,89 | 3 672 547,63 | 2 956 241,05 |
| A. Fixed assets | 127 382,32 | 931,32 | 186,32 | 0,00 | 0,00 | 35 963,15 | 30 540,95 |
| B. Current assets | 259 098,27 | 1 219 334,13 | 1 645 221,56 | 1 883 233,99 | 2 843 115,89 | 3 636 584,48 | 2 925 700,10 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 386 480,59 | 1 220 265,45 | 1 645 407,88 | 1 883 233,99 | 2 843 115,89 | 3 672 547,63 | 2 956 241,05 |
| A. Equity | 68 788,68 | 357 973,30 | 470 365,96 | 697 724,42 | 711 929,32 | 995 449,67 | 887 668,93 |
| B. Liabilities and provisions for liabilities | 317 691,91 | 862 292,15 | 1 175 041,92 | 1 185 509,57 | 2 131 186,57 | 2 677 097,96 | 2 068 572,12 |
| I. Long-term liabilities | 110 754,80 | 137 039,73 | 148 942,74 | 150 645,48 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 206 937,11 | 725 252,42 | 1 026 099,18 | 1 034 864,09 | 2 131 038,54 | 2 676 949,93 | 2 068 572,12 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.